Welcome to PakSearch.com Pakistan's Premier Business Information
Service


For business information, annual reports, laws, ordinances, regulations and articles.




Google
 
Web Paksearch.com
Cyanamid (Pakistan) Limited
Annual Report 1999
Contents
CORPORATE PROFILE
NOTICE OF ANNUAL GENERAL MEETING
REPORT OF THE DIRECTORS
AUDITORS' REPORT TO THE MEMBERS
BALANCE SHEET
PROFIT AND LOSS ACCOUNT
CASH FLOW STATEMENT
NOTES TO THE ACCOUNTS
10 YEARS HISTORY
PATTERN OF SHAREHOLDING
Corporate Profile
BOARD OF DIRECTORS
U. Mustafa Khan Chief Executive
Khwaja Bakhtiar Ahmed
Bernard Poussot
John R. Stafford (Alternate: S. Anwarul Haque)
Marco A. Fonseca (Alternate: Nadeem Tufail)
James Robertson (Alternate: Farida A. Latif)
Abbas Yaghi
Akhtar Mahmood
COMPANY SECRETARY
Khwaja Bakhtiar Ahmed
BANKERS
Citibank N. A.
Standard Chartered Bank
ABN-Amro Bank
ANZ Grindlays Bank
Bank of America NT&SA
Habib Bank Limited
Muslim Commercial Bank Limited
American Express Bank Limited
AUDITORS
Sidat Hyder Qamar & Co.
LEGAL ADVISORS
Orr. Digham & Company
Syed Qamaruddin Hassan
Legal Advisor Inc.
SHARE REGISTRAR
THK Associates (Pvt) Ltd.
Ground Floor,
Shaikh Sultan Trust Building No. 2,
Beaumont Road, Karachi.
Ph. # 5689021, 5686658
HEAD OFFICE / REGISTERED OFFICE
S-33, Hawkesbay Road, S.I.T.E.,
G.P.O. Box No. 167, Karachi.
Telephone: 2567411-34 & 111-777-333
Fax: 92-21-2564428
Notice of annual general meeting
NOTICE is hereby given that the Fifty First Annual General Meeting of Cyanamid (Pakistan) Limited will
be held on Friday, May 26, 2000, at 10.00 a.m. at the Registered Office of the Company, S-33, Hawkes Bay
Road, SITE, Karachi, to transact the following business ·
1. To confirm the minutes of the last Annual General Meeting.
2. To receive and adopt the Balance Sheet and Profit & Loss Account for the year ended
November 30, 1999 together with the Directors' and Auditors' report thereon.
3. To appoint Auditors for the year ending November 30, 2000 and to authorize Board of Directors to fix
their remuneration.
By order of the Board
KHWAJA BAKHTIAR AHMED
Karachi' May 01, 2000 Director/Company Secretary
NOTES
1. The Share Transfer Books of the Company will remain closed from May 19, 2000 to May 26, 2000 (both
days inclusive)
2. A member entitled to attend and vote at the above meeting may appoint a Proxy to attend and vote
on his behalf. A proxy need not be a member of the company. The complete Proxy Form must be
deposited at the Registered Office of the Company not less than 48 hours before the time for holding
the meeting.
3. Shareholders whose shares are deposited with Central Depository Company (CDC) are requested to
bring their Original National Identity Card and account number in CDC for verification.
Report of the directors
    
Your Directors present their Annual Report together with the Audited Accounts for the year ended November
30, 1999.
BUSINESS REVIEW
Sales
Net sales of the Legal Entity for the under review was Rs. 2,286.0 million. This reflects a growth of 13.9%
over the same period last year. The segment-wise review is given below :-
Pharmaceuticals
Domestic
Despite the deteriorating economic and trading environment that persisted during the year and continued
freeze of selling prices by the Government, your Company maintained a strong growth in Pharma
Business. Net sales of domestic market at Rs. 1,604.6 million have shown 26.1% growth over the
same period of last year. This healthy growth includes the following rationalization measures taken
as were also mentioned in our half yearly report.
-- Distribution Restructuring.
-- Product portfolio rationalization.
-- Increased focus on existing products resulted in improved volume growth.
-- Reorganization of sales force.
Export
.
Exports at Rs. 227.9 million recorded tremendous growth of 159.4% over the same period last year
owing to significant growth of export business with Russia, South Africa and Philippines. We expect
that the same trend will continue in the year 2000.
Overall growth of pharmaceutical sales was Rs. 472.2 million i.e. 34.7% over the same period last
year.
Agricultural Products
The overall industry business shrank from Rs. 10.5 billion in 1998 to Rs. 9.2 billion in 1999, a decrease
of 12.4%. Many multinationals lost 15% to 25% of their sales. In the last three years generics have
increased their market share from 17% to 40% because the farmer is increasingly price sensitive now
and prefers to use cheaper non-branded pesticides.
Net sales at Rs. 453.5 million are lower by 30.0% from last year. This significant decrease is due
to the following factors.
-- Pest infestation has been the lowest in last 6 years.
-- Deflationary prices for pesticides due to low pest infestation.
-- Volume decreased by 26% on account of heavy sales returns from the prior years' sales.
Profits
The segment-wise comments are as under :-
Pharmaceutical
Gross profit at Rs. 471.8 million is significantly higher by 62.3% against the same period last year.
This was made possible due to increased turnover and reduction in Cost of Goods Sold which is lower
by 4.3% of net sales from last year. Inspite of consistent rupee depreciation and general inflation we
have restricted our cost at a lower level and established significant savings in our Cost of Goods in
terms of purchase price by seeking out more economical sourcing of imported materials, control over
inventories, discontinuation of non-profitable products, reduction in headcount and rationalization of
manufacturing operations.
Administrative and Selling expenses are Rs. 296.6 million i.e. lower by 7.8% and 7.5% of net sales
over last year despite increasing trend in utilities, tariff, transportation and fuel prices. Operating profit
of Rs. 175.2 million in comparison to last year's operating loss of Rs. 31.1 million is mainly due to
above measures and strict control over expenses without compromising on the quality of good
manufacturing practices and principles of safety.
Agricultural Products
Gross profit at Rs. 24.8 million is lower by 81.2% against the same period last year. The significant
decrease in G.P. is due to low turnover due to lowest pest infestation, reduced selling prices, higher
discounts and increased Cost of Goods. The increase in cost primarily due to rupee depreciation and
general inflation.
Administrative and selling expenses are Rs. 171.0 million higher by 39.4% and 18.8% of net sales
over last year mainly on account of sales promotion of Stomp, hiring of more Territory Sales Officers
for 1999 season, transportation for sales returns and depreciation charged on assets deployed in
Agricenters. Operating loss at Rs. 146.2 million in comparison to last year's profit of Rs. 9.3 million
has significantly been the result of above factors.
Overall Company's Loss Before Taxation is Rs. 84.9 million as against loss of Rs. 116.6 million last year.
Despite generating an excellent operating profit in Pharma Division the total results of the Company could
not be converted into profit because of heavy losses in the Agriculture Division.
The Directors feel that the results would not have been that bad if various adverse factors had not affected
the operations of Agriculture Business.
The Company introduced one line extension i.e. Premarin VC (Conjugated Estrogens) a Harmone Replacement
Therapy for females. However your Company is determined to launch more new products and line extensions
in years 2000 and 2001.
DIRECTORS
During the year Messrs M. Mustafa Khan, Mr. Abbas Yaghi, James Robertson and Akhtar Mahmood (NIT)
joined the Board. Messrs Roger Kimmett, Luciano Giovanni DePortu, Frederick Paul Theobald III and Samir
Ahmed (NIT) left the Board. The Board of Directors wish to place on record appreciation of services rendered
by the former Directors and welcome the new Directors. Further the Board also welcomes Mr. M. Mustafa
Khan as new Chief Executive of the Company.
PROSPECTS
The Pharmaceutical industry is one of the most strictly regulated industries in the country, which has long
suffered due to strict price controls. No price increase has been forthcoming since November 1996, Future
prospects are greatly dependent on the government's policy towards the pharmaceutical industry specially
pricing. Your Company may come into a difficult situation to maintain viability of the operation unless a business
friendly, transparent and consistent basis of pricing adjustment to compensate increase in costs is decided
by the government immediately.
On our part Company's management is committed to a long-term growth strategy which is reflected by taking
the above stated measures. In addition, reorganization of the Company's distribution system is in process,
switching over from a National Distributor to Regional Distributors effective March 2000 which will help in
increasing our turnover by increasing focus in respective areas. The Company is currently engaged in
maintaining lower cost and expenses by way of rationalization of plant and reorganization/restructuring in
all areas to further strengthen the profitability and making the business viable.
SUBSEQUENT EVENTS
No material changes or commitment affecting financial position of the Company have taken place between
the end of the financial year and the date of this report.
AUDITORS
The present Auditors, M/s Sidat Hyder Qamar & Co. retire and being eligible offer themselves for reappointment.
YEAR 2000 READINESS
Year 2000 presented a very challenging scenario to the business world. In effect, it was based on the inability
of most computer programs to recognize "00" as the year 2000. Our goal was to avoid, or at least minimize
as much as possible, any disruptions as we enter the next millennium. Stated simply, the Year 2000 effort
has been one of the top priorities for the entire company.
Our parent company established a Program Management Office, the sole purpose of which was to manage
and direct the total company effort on a global basis. We addressed the Year 2000 challenge, successfully
rolled over into Year 2000 and continue to provide the same high-level customer service that was expected.
EMPLOYEES
The Directors are pleased to acknowledge that relations .between management and workers remained cordial
throughout the year.
The Directors wish to thank all employees for their hard work and devotion to duty and expect them to continue
in the same spirit in future.
PARENT COMPANIES
American Home Products Corporation incorporated in the State of Delaware, U.S.A. holds 576,470 (40.55%)
shares and American Cyanamid Company, New Jersey, U.S.A. (100% owned company of American Home
Products Corporation) holds 448,560 (31.55%) shares thus the total holding of both the companies is 72.10%.
PATTERN OF SHAREHOLDING
A statement of Pattern of Shareholding of the Company as at November 30, 1999 is shown on page 30.
Earning per share for the year is negative Rs. 79.53 (1998:Rs.101.74 negative).
By Order of the Board
Karachi: M. Mustafa Khan Khwaja Bakhtiar Ahmed
April 18, 2000 Chief Executive Director
Auditors' report to the members
We have audited the annexed balance sheet of Cyanamid (Pakistan) Limited as at 30 November 1999
and the related profit and loss account and the statement of changes in financial position, together with
the notes forming pad thereof, for the year then ended and we state that we have obtained all the information
and explanations which to the best of our knowledge and belief were necessary for the purposes of our
audit and, after due verification thereof, we report that:
a) in our opinion, proper books of account have been kept by the Company as required by the
Companies Ordinance, 1984;
b) in our opinion:
i) the balance sheet and profit and loss account together with the notes thereon have been drawn
up in conformity with the Companies Ordinance, 1984, and are in agreement with the books
of account and are further in accordance with accounting policies consistently applied;
ii) the expenditure incurred during the year was for the purposes of the Company's business; and
iii) the business conducted, investments made and the expenditure incurred during the year were
in accordance with the objects of the Company;
c) in our opinion and to the best of our information and according to the explanations given to us,
the balance sheet, profit and loss account and the statement of changes in financial position, together
with the notes forming part thereof, give the information required by the Companies Ordinance, 1984,
in the manner so required and respectively give a true and fair view of the state of the Company's
affairs as at 30 November 1999 and of the loss and the changes in financial position for the year
then ended; and
d) in our opinion no zakat was, deductible at source under the Zakat and Ushr Ordinance, 1980
Sidat Hyder Qamar & Co.
Chartered Accountants
Karachi: April 26, 2000
BALANCE SHEET AS AT 30 NOVEMBER 1999
Note 1999 1998
(Rupees '000)
Fixed Assets - Tangible 3 157,617 170,373
Capital work-in-progress -- 37
Goodwill 4 6,701 8,376
Long term loans, deposits and prepayments 5 20,967 15,767
CURRENT ASSETS
Stores, spares and loose tools 6 39,985 41,405
Stock-in-trade 7 945,046 742,425
Trade debts 8 325,622 374,167
Loans, advances, deposits, prepayments and
other receivables 9 28,744 54,685
Taxation - net 10 307,959 206,916
Cash and bank balances 11 10,218 2,601
---------- ----------
1,657,574 1,422,199
LESS: CURRENT LIABILITIES
Current maturity of liability against assets
subject to finance leases 17 7,942 8,226
Short term loans- unsecured 12 712,040 --
Running finance under mark-up arrangements- secured 13 72,915 592,846
Creditors, accrued and other liabilities 14 717,559 561,156
Unclaimed dividend 541 10,871
---------- ----------
1,510,997 1,173,099
---------- ----------
NET CURRENT ASSETS 146,577 249,100
---------- ----------
331,862 443,653
========== ==========
REPRESENTED BY
Share capital 15 142,161 142,161
Reserves 16 382,147 382,147
Accumulated loss 16 (256,173) (143,109)
---------- ----------
268,135 381,199
Liability against assets subject to finance leases 17 15,082 17,238
Deferred liability- Staff gratuity and pension 48,645 45,216
CONTINGENCIES AND COMMITMENTS 18 -- --
---------- ----------
331,862 443,653
========== ==========
The annexed notes form an integral part of these accounts.
M. Mustafa Khan Khwaja Bakhtiar Ahmed
Chief Executive Director
PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDED 30 NOVEMBER 1999
Note 1999 1998
(Rupees '000)
Sales-net 19 2,286,040 2,007,853
Cost of goods sold 20 1,789,484 1,585,125
---------- ----------
Gross profit 496,556 422,728
Administrative and selling expenses 21 467,618 444,564
---------- ----------
Operating profit/(loss) 28,938 (21,836)
Other income 22 10,610 5,423
---------- ----------
39,548 (16,413)
Financial charges 23 122,814 98,478
Amortization of goodwill 4 1,675 1,675
---------- ----------
124,489 100,153
---------- ----------
Loss before taxation (84,941) (116,566)
Taxation
Current 20,670 23,265
Prior years' 7,453 8,156
Deferred -- (3,356)
---------- ----------
28,123 28,065
---------- ----------
Loss after taxation (113,064) (144,631)
Accumulated loss brought forward (143,109) 1,522
---------- ----------
Accumulated loss carried forward (256,173) (143,109)
========== ==========
Rupees Rupees
Loss per share - Basic and diluted 24 79.532 101.738
========== ==========
The annexed .notes form an integral part of these accounts.
M. Mustafa Khan Khwaja Bakhtiar Ahmed
Chief Executive Director
CASH FLOW STATEMENT FOR THE YEAR ENDED 30 NOVEMBER 1999
Note 1999 1998
(Rupees '000)
CASH FLOW FROM OPERATING ACTIVITIES
Cash generated from / (used in) operations 29 55,870 167,482
Interest and mark-up paid (43,493) (93,158)
income tax paid (129,166) (129,047)
Lease financial charges paid (3,557) (4,486)
Payment of gratuity and pension (16,069) (3,841)
Increase in Long-term loans, deposits and prepayments (5,200) (3,059)
----------- -----------
(197,485 (233,591)
Net cash outflow from operating activities (141,615) (66,109)
CASH FLOW FROM INVESTING ACTIVITIES
Fixed capital expenditure (35,062) (41,141)
Sale proceeds of fixed assets 4,955 5,953
Net cash outflow from investing activities (30,107) (35,188)
CASH FLOW FROM FINANCING ACTIVITIES
Dividend paid (10,330) (3,713)
Increase/(Decrease) in shod term loans 712,040 (419,070)
Increase/(Decrease) in liabilities against assets
subject to finance leases (2,440) 11,015
----------- -----------
699,270 (411,768)
----------- -----------
527,548 (513,065)
(590,245) (77,180)
----------- -----------
30 (62,697) (590,245)
========== ==========
The annexed notes form an integral part of these accounts.
M. Mustafa Khan Khwaja Bakhtiar Ahmed
Chief Executive Director
NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 30 NOVEMBER 1999
1. STATUS AND NATURE OF BUSINESS
Cyanamid (Pakistan) Limited is a public limited company quoted on the Karachi and Lahore Stock
Exchanges. The current business activities of the Company consist of the manufacture and marketing
of research based ethical specialties and other pharmaceutical and agro - chemical products.
2. SIGNIFICANT ACCOUNTING POLICIES
2.1 Accounting convention and basis of preparation
These accounts have been prepared under the historical cost convention and in accordance with
the International Accounting Standards as applicable in Pakistan.
2.2 Fixed assets, capital work in progress and depreciation
(a) Owned
Fixed assets are stated at cost less accumulated depreciation except for freehold land,
leasehold land and capital work in progress which are stated at cost.
Depreciation is charged to income applying the straight line method. Due to reassessment
of the remaining useful lives of its operating assets in the previous year, the Company
considered the net book values of these assets as at 01 December 1997 to be written
off over the remaining useful lives of the assets under the straight line method. Full year's
depreciation is charged on additions during the year while no depreciation is charged for
the assets disposed off during the year.
Maintenance and normal repairs are charged to income as and when incurred. Gain or
loss on sale or retirement of fixed assets is included in income currently.